Caribou Biosciences, Inc. (CRBU) Pre-Tax Margin
- 2021-12-31: Pre-Tax Margin -709.57%.
- 2021-09-30: Pre-Tax Margin -527.38%.
- 2021-06-30: Pre-Tax Margin -969.58%.
- 2020-12-31: Pre-Tax Margin -1530.18%.
Complete source-backed pre-tax margin history.
- Available history
- 2019-12-31 to 2025-12-31
- Data captured
Historical Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2021-12-31 | -709.57% |
| 2021-09-30 | -527.38% |
| 2021-06-30 | -969.58% |
| 2020-12-31 | -1530.18% |
| 2020-09-30 | -679.97% |
| 2020-06-30 | -22.67% |
Annual Pre-Tax Margin
| Date | Pre-Tax Margin |
|---|---|
| 2025-12-31 | -1332.33% |
| 2024-12-31 | -1492.04% |
| 2023-12-31 | -295.49% |
| 2022-12-31 | -717.28% |
| 2021-12-31 | -693.92% |
| 2020-12-31 | -292.27% |
| 2019-12-31 | -535.04% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |